BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23124896)

  • 21. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.
    Albiñana V; Recio-Poveda L; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2012 Jul; 108(1):41-53. PubMed ID: 22552254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Expression of Circulating Plasma miRNA-370 and miRNA-10a from Patients with Hereditary Hemorrhagic Telangiectasia.
    Ruiz-Llorente L; Albiñana V; Botella LM; Bernabeu C
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
    Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
    Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.
    Lesca G; Olivieri C; Burnichon N; Pagella F; Carette MF; Gilbert-Dussardier B; Goizet C; Roume J; Rabilloud M; Saurin JC; Cottin V; Honnorat J; Coulet F; Giraud S; Calender A; Danesino C; Buscarini E; Plauchu H;
    Genet Med; 2007 Jan; 9(1):14-22. PubMed ID: 17224686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three novel mutations in the activin receptor-like kinase 1 (ALK-1) gene in hereditary hemorrhagic telangiectasia type 2 in Brazilian patients.
    Assis AM; Costa FF; Arruda VR; Annichino-Bizzacchi JM; Bertuzzo CS
    J Hum Genet; 2007; 52(3):237-243. PubMed ID: 17219009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes.
    Sanz-Rodriguez F; Fernandez-L A; Zarrabeitia R; Perez-Molino A; Ramírez JR; Coto E; Bernabeu C; Botella LM
    Clin Chem; 2004 Nov; 50(11):2003-11. PubMed ID: 15375013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects.
    Lenato GM; Guanti G
    Curr Pharm Des; 2006; 12(10):1173-93. PubMed ID: 16611099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.
    Bayrak-Toydemir P; McDonald J; Markewitz B; Lewin S; Miller F; Chou LS; Gedge F; Tang W; Coon H; Mao R
    Am J Med Genet A; 2006 Mar; 140(5):463-70. PubMed ID: 16470787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
    Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
    Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.
    Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C
    Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).
    Ojeda-Fernandez L; Barrios L; Rodriguez-Barbero A; Recio-Poveda L; Bernabeu C; Botella LM
    Clin Chim Acta; 2010 Apr; 411(7-8):494-9. PubMed ID: 20067780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.
    Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M
    Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress contributes to endothelial dysfunction in mouse models of hereditary hemorrhagic telangiectasia.
    Jerkic M; Sotov V; Letarte M
    Oxid Med Cell Longev; 2012; 2012():686972. PubMed ID: 23320130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients.
    Letteboer TG; Zewald RA; Kamping EJ; de Haas G; Mager JJ; Snijder RJ; Lindhout D; Hennekam FA; Westermann CJ; Ploos van Amstel JK
    Hum Genet; 2005 Jan; 116(1-2):8-16. PubMed ID: 15517393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.
    Letteboer TG; Mager HJ; Snijder RJ; Lindhout D; Ploos van Amstel HK; Zanen P; Westermann KJ
    Am J Med Genet A; 2008 Nov; 146A(21):2733-9. PubMed ID: 18831062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
    Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMAD4 mutations found in unselected HHT patients.
    Gallione CJ; Richards JA; Letteboer TG; Rushlow D; Prigoda NL; Leedom TP; Ganguly A; Castells A; Ploos van Amstel JK; Westermann CJ; Pyeritz RE; Marchuk DA
    J Med Genet; 2006 Oct; 43(10):793-7. PubMed ID: 16613914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation.
    Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
    Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
    Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.